Austin, TX -- (SBWIRE) -- 05/02/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
Exelixis, Inc. (NASDAQ:EXEL) shares fell 8.67% and closed at $4.74. The company, on April 9, announced the presentation of preclinical data that provide insight into the mechanism of action of its lead compound, cabozantinib, with respect to its activity against prostate cancer tumors that have metastasized to the bone.
Additionally, the company will release its first quarter 2013 financial results on Tuesday, May 7, 2013 after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT.
Can EXEL Continue To Move Higher? Find Out Here
Ellie Mae Inc (NYSE:ELLI) shares decreased 8.53% to $23.80. The company, on May 1, reported results for the first quarter ended March 31, 2013. Total revenue for the first quarter of 2013 increased 48% to $30.9 million, compared to $20.9 million in the first quarter of 2012. Net income for the first quarter of 2013 was $3.9 million, or $0.14 per diluted share, compared to net income of $3.6 million, or $0.16 per diluted share, in the first quarter of 2012.
On a non-GAAP basis, adjusted net income for the first quarter of 2013 was $7.6 million, or $0.27 per diluted share, compared to $4.6 million, or $0.20 per diluted share, in the first quarter of 2012.
Can ELLI Extend Gain? Find Out Here
Canadian Solar Inc.(NASDAQ:CSIQ) shares fell 8.53% to $5.15. The company on April 26 announced the filing of its annual report on Form 20-F for the year ended December 31, 2012 with the U.S. Securities and Exchange Commission ("SEC").
Additionally, the company on April 2, announced that the United States District Court for the Southern District of New York dismissed with prejudice a class action lawsuit filed against the Company and certain named defendants. The lawsuit alleged that the Company's financial disclosures during 2009 and early 2010 were false or misleading and in violation of federal securities law.
How Should Investors Trade CSIQ Now? Find Out Here
IPG Photonics Corporation (NASDAQ:IPGP) shares declined 8.49 and closed at $58.17 in the last trading session. The company on May 1 reported first quarterly net income of $35 million or $0.67 per share, compared to $30 million or $0.61 a share last year. Analysts expected earnings of $0.70 per share for the quarter. Revenues for the quarter rose 15 percent to $142 million from $123 million in the prior year. Analysts on consensus estimated revenues of $150.34 million.
How Should Investors Trade IPGP Now? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)